Enlivex Ltd. (ENLV)
NASDAQ: ENLV · Real-Time Price · USD
1.270
+0.070 (5.83%)
Nov 19, 2026, 10:24 AM EST - Market open
Enlivex Market Cap
Enlivex has a market cap or net worth of $1.58 million as of November 19, 2026. It is the 48,577th most valuable company in the world and the 6,454th biggest in the United States. Its market cap has decreased by 93.44% in one year.
Market Cap
1.58M
Enterprise Value
13.61M
1-Year Change
-93.44%
Global Rank
Country Rank
#6,454 United States
Category
ChartMarket Cap Chart
Since March 26, 2019, Enlivex's market cap has decreased from $101.63M to $1.58M, a decrease of -98.45%. That is a compound annual growth rate of -41.97%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 17, 2026 | 1.43M | -99.14% |
| Dec 31, 2025 | 166.93M | 548.82% |
| Dec 31, 2024 | 25.73M | -48.77% |
| Dec 29, 2023 | 50.22M | -30.73% |
| Dec 30, 2022 | 72.50M | -36.72% |
| Dec 31, 2021 | 114.57M | -5.58% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 26, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| 60 Degrees Pharmaceuticals | 1.88M |
| HCW Biologics | 1.74M |
| BioRestorative Therapies | 1.71M |
| Clearmind Medicine | 1.45M |
| Genprex | 1.37M |
| Kairos Pharma | 1.35M |
| Aptevo Therapeutics | 1.23M |
| PMGC Holdings | 1.20M |